NEU neuren pharmaceuticals limited

Ann: 2024 results - A$166m comprehensive income for shareholders, page-14

  1. 491 Posts.
    lightbulb Created with Sketch. 95
    My favourite sentence from the report? The financial foundation this
    gives Neuren to target repeating the success on a larger scale with NNZ-2591 across multiple indications
    should not be underestimated.”

    ..."should not be underestimated".

    I just changed my sentiment to 'buy"
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$13.31
Change
0.770(6.14%)
Mkt cap ! $1.655B
Open High Low Value Volume
$12.96 $14.00 $12.91 $19.76M 1.453M

Buyers (Bids)

No. Vol. Price($)
1 3000 $13.30
 

Sellers (Offers)

Price($) Vol. No.
$13.33 3716 1
View Market Depth
Last trade - 16.10pm 26/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.